Our results showed that paeoniflorin, at similar non-toxic doses as those used in the transcriptomic analysis, reduced the levels of BACH1 (total, nuclear and cytoplasmic levels) in lung and breast cancer cell lines (Fig. 4B and C). Here, BACH1 is linked to breast cancer.